Hextar Healthcare Berhad (KLSE:HEXCARE)
Malaysia
· Delayed Price · Currency is MYR 0.1300
0.00 (0.00%)
At close: Apr 25, 2025
Hextar Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 146.95 | 154.76 | 174.97 | 509.95 | 415.15 | Upgrade
|
| Other Revenue | - | 1.72 | 5.42 | 4.72 | 1.5 | Upgrade
|
| Revenue | 146.95 | 156.49 | 180.38 | 514.67 | 416.64 | Upgrade
|
| Revenue Growth (YoY) | -6.09% | -13.25% | -64.95% | 23.53% | 89.82% | Upgrade
|
| Cost of Revenue | 157.9 | 99.53 | 123.17 | 160.09 | 158.91 | Upgrade
|
| Gross Profit | -10.95 | 56.96 | 57.21 | 354.58 | 257.74 | Upgrade
|
| Selling, General & Admin | 15.08 | 39.88 | 37.73 | 48.16 | 40.81 | Upgrade
|
| Other Operating Expenses | -9.66 | 60.73 | 47.55 | 63.13 | 43.28 | Upgrade
|
| Operating Expenses | 5.42 | 120.1 | 100.21 | 124.62 | 92.92 | Upgrade
|
| Operating Income | -16.37 | -63.14 | -43 | 229.96 | 164.82 | Upgrade
|
| Interest Expense | -0.27 | -0.5 | -0.2 | -0.1 | -0.27 | Upgrade
|
| Interest & Investment Income | - | 0.03 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Earnings From Equity Investments | -2.34 | -0.09 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.15 | -0.11 | 1.71 | 0.49 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.31 | -0.41 | -0.33 | -0.32 | Upgrade
|
| EBT Excluding Unusual Items | -18.98 | -63.85 | -43.71 | 231.25 | 164.74 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.02 | -0.02 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -1.22 | -0.03 | 5.95 | -1.33 | Upgrade
|
| Asset Writedown | - | -8.58 | -20 | -0.42 | -2.37 | Upgrade
|
| Other Unusual Items | - | -0.02 | 0.58 | - | - | Upgrade
|
| Pretax Income | -18.98 | -73.64 | -63.18 | 236.78 | 161.04 | Upgrade
|
| Income Tax Expense | -5.06 | -9.26 | -7.49 | 51.04 | 29.86 | Upgrade
|
| Earnings From Continuing Operations | -13.92 | -64.38 | -55.69 | 185.74 | 131.18 | Upgrade
|
| Net Income | -13.92 | -64.38 | -55.69 | 185.74 | 131.18 | Upgrade
|
| Net Income to Common | -13.92 | -64.38 | -55.69 | 185.74 | 131.18 | Upgrade
|
| Net Income Growth | - | - | - | 41.60% | 394.81% | Upgrade
|
| Shares Outstanding (Basic) | 1,045 | 1,002 | 895 | 852 | 803 | Upgrade
|
| Shares Outstanding (Diluted) | 1,045 | 1,002 | 895 | 852 | 803 | Upgrade
|
| Shares Change (YoY) | 4.28% | 11.94% | 5.08% | 6.13% | 6.08% | Upgrade
|
| EPS (Basic) | -0.01 | -0.06 | -0.06 | 0.22 | 0.16 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.06 | -0.06 | 0.22 | 0.16 | Upgrade
|
| EPS Growth | - | - | - | 33.42% | 366.46% | Upgrade
|
| Free Cash Flow | -34.99 | -28.71 | -34.96 | 99.09 | 79.7 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.04 | 0.12 | 0.10 | Upgrade
|
| Gross Margin | -7.45% | 36.40% | 31.71% | 68.89% | 61.86% | Upgrade
|
| Operating Margin | -11.14% | -40.34% | -23.84% | 44.68% | 39.56% | Upgrade
|
| Profit Margin | -9.47% | -41.14% | -30.87% | 36.09% | 31.48% | Upgrade
|
| Free Cash Flow Margin | -23.81% | -18.34% | -19.38% | 19.25% | 19.13% | Upgrade
|
| EBITDA | 0.85 | -45.91 | -28.57 | 242.47 | 172.8 | Upgrade
|
| EBITDA Margin | 0.58% | -29.34% | -15.84% | 47.11% | 41.47% | Upgrade
|
| D&A For EBITDA | 17.23 | 17.23 | 14.43 | 12.51 | 7.98 | Upgrade
|
| EBIT | -16.37 | -63.14 | -43 | 229.96 | 164.82 | Upgrade
|
| EBIT Margin | -11.14% | -40.34% | -23.84% | 44.68% | 39.56% | Upgrade
|
| Effective Tax Rate | - | - | - | 21.56% | 18.54% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.